Changeflow GovPing Pharma & Drug Safety Recombinant Lubricin Patent - Schmidt and Jay I...
Routine Notice Added Final

Recombinant Lubricin Patent - Schmidt and Jay Inventors

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

USPTO published patent application US20260098069A1 for recombinant isoforms of human-like lubricin (PRG4 glycoprotein) invented by Tannin A. Schmidt and Gregory D. Jay. The patent covers new lubricin isoforms with novel glycosylation patterns and methods for commercial-scale manufacturing using recombinant production methods.

What changed

USPTO published international patent application US20260098069A1 on April 9, 2026, covering recombinant isoforms of human-like lubricin (PRG4 glycoprotein) invented by Schmidt and Jay. The application discloses lubricin variants with enhanced lubrication properties and novel glycosylation patterns, along with manufacturing methods enabling commercial-scale production at high expression levels.

For biotechnology and pharmaceutical companies developing synovial joint therapies, dermal lubricants, or ocular applications, this patent establishes prior art in the recombinant lubricin space. Competitors must assess freedom-to-operate before entering this field. The patent's broad glycosylation and production method claims may require licensing negotiations for commercialization of similar recombinant products.

What to do next

  1. Monitor patent claims for freedom-to-operate analysis
  2. Evaluate licensing opportunities for recombinant lubricin production
  3. Review patent scope for competitive R&D implications

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PRODUCTION OF RECOMBINANT LUBRICIN

Application US20260098069A1 Kind: A1 Apr 09, 2026

Inventors

Tannin A. Schmidt, Gregory D. Jay

Abstract

Disclosed are new recombinant isoforms of human-like lubricin or PRG4 glycoprotein having outstanding lubrication properties and a novel glycosylation pattern, and methods for their manufacture at high levels enabling commercial production.

CPC Classifications

C07K 14/4725 A61K 9/0014 A61K 9/0019 A61K 9/0048 A61K 9/008 A61K 31/728 A61K 38/1709 A61K 47/36 C12P 21/005

Filing Date

2025-10-06

Application No.

19350714

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260098069A1

Who this affects

Applies to
Pharmaceutical companies Biotechnology companies Medical device makers
Industry sector
3254.1 Biotechnology
Activity scope
Patent application publication Biotechnology research Recombinant protein manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!